Intranasal administration of defective interfering (DI) influenza virus (A/WSN) ensured the survival of 80 ~ of C3H mice otherwise lethally infected with WSN by the intranasal route, whereas a control group which received fl-propiolactone-inactivated DI virus in place of DI virus died at 7.4 days post-infection. DI virus-treated mice developed significantly less lung consolidation than controls although qualitatively the cellular pathology in the two groups was indistinguishable. Surprisingly, in view of the accepted mode of action of DI virus interference, multiplication of infectious virus in the lung, production of viral haemagglutinin (HA) antigen and neuraminidase, and the distribution and amount of viral antigen in cells as shown by immune labelling were unaffected by the presence of active DI virus. Furthermore, assays of lung extracts showed that DI virus was not stimulating significantly greater amounts of interferon than the control inactivated DI virus. An alternative explanation arises from the fact that the pathology of influenza in inbred mice is immune (T lymphocyte)-mediated. Thus, since there is no evidence that DI virus affects virus multiplication we suggest that DI virus is responsible for ameliorating the damaging host responses. Another aspect of the immune response modulated by DI virus was the enhancement of local haemagglutination-inhibiting (HI) antibody in the lung, with peak increases of up to 10-fold over the relevant controls being demonstrated at 5 days after infection. This antibody was presumably complexed to HA antigen in the lung as activity was only demonstrated after elution at low pH. It had no detectable neutralizing activity (< 10 HI : neutralization ratio of convalescent serum) which accounts for the coexistence of local antibody and virus infectivity. Mice infected with virus alone or which received flpropiolactone-inactivated DI virus in addition to a lethal dose of WSN did not develop significant amounts of lung antibody. No differences were seen in serum HI titres. The increased level of antibody could not be attributed to the presence of greater amounts of HA antigen in lungs of mice treated with DI virus, as ELISA showed no significant difference from control preparations. The possibility that the two modulated immune responses are linked through HI antibody blocking access of T cells to cell membraneborne HA antigen is discussed.
INTRODUCTION
Defective interfering (DI) viruses are naturally occurring mutants which often have a deletion consisting of the majority of the standard (infectious) virus genome. They depend on the standard virus for multiplication and during this interaction diminish the yield of infectious progeny. Much more is known about the biochemistry of DI virus particles than about how they arise, how they become rapidly enhanced in the virus population or how they interfere (Nayak, 1980; Perrault, 1981; Lazzarini et al., 1981; Nayak et al., 1985) . However, experiments in cultured cells show that interference occurs intracellularly and acts at the level of virus 0000-6952©1986 SGM replication. Little is known about the role of DI viruses during natural infections although it has been pointed out that they have the capacity to ameliorate virulent infection or cause infections to become persistent (Huang & Baltimore, 1970; Dimmock, 1985; Barrett & Dimmock, 1986) . In vivo laboratory infections with vesicular stomatitis virus (VSV) Holland & Villarreal, 1975; Rabinowitz et al., 1977; Crick & Brown, 1977; Fultz et al., 1981 Fultz et al., , 1982a , rabies virus (Wiktor et al., 1977; Clark et al., 1981) , reovirus (Spandidos & Graham, 1976) , influenza virus (Bernkopf, 1950; yon Magnus, 1951 ; Gamboa et al., 1976; Rabinowitz & Huprikar, 1979) , lymphocytic choriomeningitis virus (Welsh et al., 1977) , Banzi virus (Smith, 1981) , and Rift Valley fever virus (Mires, 1956) show that DI viruses do indeed exert a sparing effect, but it is uncertain that this is due to the interfering activity of the DI virus as no 'inactive' virus was used to control for stimulation of immune responses by DI virus antigen. Nonetheless, carefully controlled experiments using inactivated viral antigen in place of DI virus with VSV (Jones & Holland, 1980; Fultz et al., 1982 a) and Semliki Forest virus (SFV) (Dimmock & Kennedy, 1978; Crouch et al., 1982; Barrett & Dimmock, 1984a, b; showed that DI viruses are indeed powerful modulators of infection. As a result of administering DI virus, the acute infection may become entirely subclinical (SFV: Dimmock & Kennedy, 1978; Barrett & Dimmock, 1984a, b) or converted to a chronic wasting condition (VSV inoculated intracerebrally: reovirus: Spandidos & Graham, 1976) or a long-term persistent infection (VSV inoculated intraperitoneally : Fultz et al., 1982 a; SFV: T. Atkinson, A. D. T. Barrett, A. Mackenzie & N. J. Dimmock, unpublished data) . However, almost nothing is known of how DI virus and host interact to bring about these profound changes in the expression of disease.
VSV and SFV both cause disease of the central nervous system which is the result of lysis predominantly of neuronal cells by the virus. Thus, it was of interest to study the influenzamouse model as an example of a disease which arises from an essentially superficial infection and which has an immune-mediated pathology (see Discussion). Previous results suggesting that a DI virus could be immunosuppressive (Barrett & Dimmock, 1984b) were also relevant to this choice of an experimental system showing immune-mediated disease. Although early work suggested that DI virus could modulate pulmonary infection of the mouse (Bernkopf, 1950; yon Magnus, 1951) , subsequent work failed to demonstrate any protective activity of DI influenza virus and others concluded that a sparing effect was due to stimulation of humoral immunity rather than to the interfering activity of the DI virus itself (Rabinowitz & Huprikar, 1979) .
Like all other DI viruses, DI influenza viruses obtain their structural proteins from the pools synthesized by standard virus; hence, DI and standard virus are antigenically identical. DI viruses are typified by the presence of extra virion RNA segments, usually smaller than that of the smallest (segment 8) virion RNA (Crumpton et al., 1978; Nayak et al., 1978) , and the reduction of the largest virion RNAs (segments 1, 2 and 3). Much is known about the sequence of these RNAs and it is clear that they are highly variable although the majority are derived by deletion events and other sequence rearrangements from virion segments 1, 2 and 3 (Nayak & Sivasubramanian, 1983; Nayak et al., 1985) .
In this study, we have examined the effects of administration of DI influenza virus on lethal influenza in vivo. We find that DI virus prevents death whereas fl-propiolactone (BPL)-inactivated DI virus has no effect on the outcome of infection. However, DI virus did not inhibit the extent or location of multiplication of standard virus; hence, we suggest that DI virus modulates the host activity responsible for the immune-mediated pathology.
METHODS
Cells. Chick embryo fibroblast (CEF) cells were used as primary cultures (Morser et al., 1973) . Madin-Darby canine kidney (MDCK) cells were obtained originally from Flow Laboratories and grown by standard procedures.
Virus. Influenza virus A/WSN (H IN 1) was plaque-purified extensively before use in these experiments in primary CEF cells using a serum-free overlay medium. Stocks of infectious (standard) virus were made by inoculating the allantoic cavity of I 1-day-old chick embryos with about 103 p.f.u, and incubating for 2 days at 33 °C. Viral haemagglutinin (HA) was assayed by detecting the presence of virus in doubling dilutions with chick erythrocytes.
Defective interfering virus. DI virus was produced by inoculating about 109 p.f.u, standard virus into the allantoic cavity of embryonated chickens' eggs and incubating overnight at 33 °C. Usually three passages were sufficient to show a decrease in p.f.u. :HA ratio from about 106 to 103. This loss of specific infectivity correlated with an increase in interference in vitro, measured by assays which used the ability of DI virus to prevent cytopathic effects caused by standard WSN (unpublished data). In this assay MDCK cells in microtitre trays were infected at a m.o.i, of 10 p.f.u./cell with standard virus before being inoculated with serial dilutions of DI virus. After 30 h incubation at 37 °C monolayers were fixed and stained with crystal violet to determine the extent of cytopathic effects. The very sharp endpoints enabled the interference titre to be interpolated as the reciprocal of the dilution of DI virus that produced 50% inhibition. DI virus stocks were stored as allantoic fluid in liquid nitrogen as there were indications that interference was less stable than virus infectivity at -70 °C.
Mice. C3H/He Mg mice were originally obtained from Banting and Kingman Ltd (Grimston, Aldbrough, Hull, U.K.) and used at 5 weeks. Both sexe~ proved equally susceptible to WSN and were therefore used interchangeably. Mice were inoculated int,~oasally with 20 ~tl of virus in phosphate-buffered saline (PBS) after ether anaesthesia and were held at 22 °C with 12 h of light.
Before inoculation into mice, DI virus was pelleted from allantoic fluid and resuspended in PBS at a concentration of 104 HAU/ml or 107 defective interfering units/ml. Since DI and standard influenza virus particles cannot be physically separated, infectivity was removed by u.v. irradiation. This is possible as infectious virus has a genome about 20-fold greater in size than DI virus; hence, infectivity is inactivated while the majority of interfering activity is retained (unpublished data). Irradiated DI virus was divided into two lots, one of which was incubated with 0.01% BPL for 10 h at 4 °C (Barrett et al., 1984a) to inactivate interfering activity (see Results). BPL was removed by overnight dialysis against excess PBS. Mice were inoculated with 200 HAU DI virus or BPL-inactivated DI (BPL DI) virus 2 h before infection and simultaneously co-inoculated with 200 HAU DI virus or BPL DI virus and 4 LDs0 (4000 p.f.u.) standard WSN (Dimmock & Kennedy, 1978) .
Mice were killed at intervals (on day 1 post-infection and then on alternate days up to day 15 and on days 20 and 52) by gassing with ether. Blood was obtained from the heart, and the lungs were removed and rinsed free of blood. The right lung was processed for histological assessment (see below). The left lung was stored at -70 °C and later ground with sand in a mortar and pestle. After low-speed centrifugation, the supernatant was stored in aliquots at -70 °C until required.
Interferon assay. Virus present was inactivated with BPL (Barrett et al., 1984a and see above) under conditions that permit the survival of the antiviral activities of alpha, beta and gamma interferons. These were assayed by their inhibition of synthesis of RNA by SFV (Atkins et al., 1974) using L cells and the assay modified for use in microtitre plates. Determination of alpha/beta interferon was accomplished by first inactivating gamma interferon at pH 3. Material was then dialysed back to neutral pH.
Haemagglutination-inhibiting (HI) antibody assay. HI assays were performed by standard methods using 4 HAU and doubling dilutions of sera or the supernatant fluids from lung extracts. Supernatants were dialysed against a solution at pH 3 for 6 h to release any antibody which was complexed to antigens. The pH was returned to neutrality by dialysis overnight before assay for antibody.
ELISA for WSN HA antigen. Monospecific rabbit antiserum made against a reassortant having the haemagglutinin of A/NWS and the neuraminidase of A/Jap/305/57 (H1N2) was obtained by exhaustive adsorption with an ether-disrupted H3N2 virus. Anti-NWS HA reacts strongly with WSN HA. The adsorbed serum contained no detectable activity against viral NP, M or WSN neuraminidase and gave a single precipitin line by the Ouchterlony test (data not shown). This anti-HA was bound to wells of a microtitre tray and was used to capture viral HA antigen from lung extract (diluted in PBS containing 0.01% Tween 20) which was detected using a sandwich of mouse antibody to WSN and goat anti-mouse IgG conjugated with peroxidase (Nordic Immunological Laboratories, Maidenhead, U.K.). The coloured moiety released from o-phenylenediamine (Sigma) was estimated spectrophotometrically at 492 nm on a Microelisa Mini Reader MR590 (Dynatech Laboratories, Alexandria, Va., U.S.A.).
Pathology. The proportion of the lung parenchyma showing consolidation was estimated grossly. For histopathological assessment the right lung of each mouse was immersed in 10% formol saline, processed by standard techniques and stained with haematoxylin and eosin. For immunopathological examination adjacent sections were stained with a hyperimmune rabbit serum prepared against purified WSN. This antiserum reacted with HA, NA, NP and M antigens as shown by Western blotting of polypeptides separated by polyacrylamide gel electrophoresis. Antibody reacting in lung sections was demonstrated by a second peroxidase-linked anti-rabbit IgG (Nordic Immunological Laboratories).
RESULTS

Infection by WSN
Mice given 4 LDs0 (4000 p.f.u.) by the intranasal route died from 7 to 9 days after infection (data not shown). inactivated DI virus 2 h before infection and of a second dose simultaneously with the infectious virus ( Fig. 1, upper curve) . The mean day of death over several experiments was 7.4 +_ 0.9. Thus, this amount of viral antigen neither prevents infection nor stimulates protective immune responses which influence the course of disease. Infection of the lung was accompanied by consolidation which was apparent from day 3 post-infection and increased to involve over 75 of the lung parenchyma by the time of death. Death from influenza virus in inbred mice is caused by an immune-mediated (T cell) pathological process as described above. Infectivity assays confirmed that in our system the target organ is the lung and little or no virus was present in serum, spleen or brain (data not shown).
Protection mediated by DI WSN in mice C3H mice were co-inoculated as described in Methodswith either DI WSN and 4 LDs0 WSN or BPL-inactivated DI WSN and 4 LD50 WSN. Fig. 1 and 2 show that DI WSN delayed the onset of consolidation and prevented death with a net survival rate of 80~. Clinically, all mice showed signs of respiratory infection but in the DI virus-treated animals these developed later and were less severe than in the controls. DI virus-treated mice started to recover by 7 days postinfection and by 9 days were clinically normal.
Gross lung pathology was quantified by estimating the percentage of consolidation present (Fig. 2) . Its onset was consistent with the sequence of clinical disease already mentioned. Clearly, the DI virus-treated mice were infected but the time of appearance of consolidation was delayed and reached less than 50~ of total lung area before regressing from day 9.
Control mice which were inoculated with DI virus alone or BPL-inactivated DI virus alone did not become ill and their lungs showed no sign of consolidation.
Histopathological appearances
The right lung of each mouse was used to determine the pathological changes in each group. In the BPL DI virus-treated group, infected mice showed increased stratification and mitoses in the epithelium of the smaller airways on day 1. This was more marked at day 3, but in addition there was a lymphocytic and polymorphonuclear leukocyte (PMNL) infiltration producing focal bronchiolitis and a patchy interstitial pneumonia. At days 5 and 7, all mice showed a varying degree of bronchiolitis and pneumonia with an alveolar exudate of mainly lymphocytes with some PMNL. BPL DI virus-treated mice died at 8 to 9 days post-infection. Mice treated with active DI virus showed no qualitative histological difference from the group treated with BPL DI virus up to this stage. In this strain of mice (C3H/He Mg) few lung macrophages are normally present and there was no histological evidence of recruitment of macrophages in either group. In DI virus-treated mice, the changes showed signs of resolution at day 9 and there were regenerative polyps in the airways. Recovery continued through day 11 and by day 13 the bronchial divisions were clear and the wails repaired; the interstitial/alveolar infiltrate was patchy and mild and there was marked alveolar cell metaplasia. There was little difference at day 15 but by day 20, two of five mice were fully recovered and three still had a focal peribronchial, interstitial and alveolar infiltrate. At day 52 eight of nine mice had essentially normal lung architecture, but the other was abnormal and showed focal peribronchial and interstitial fibrosis. In contrast to this progressive recovery, the lungs of two BPL DI virus-treated mice surviving at 11 days showed no sign of resolution with nearly confluent consolidation. Histologically, they still had active bronchial damage and a dense parenchymal cellular infiltrate. In some areas, consolidation was due to alveolar epithelial cell proliferation.
Virus multiplication
Infectivity in lung extracts increased rapidly over the first 24 h in BPL DI virus-treated animals, reaching a maximum of over 106 p.f.u./g at 5 days post-infection (Fig. 3) . However, no HA was detected. Surprisingly, the titres in mice co-inoculated with active DI virus were indistinguishable from the control group, leading us to conclude that DI WSN did not interfere with virus multiplication in vivo although in vitro it clearly has this capacity. Titres in both groups fell by 100-fold at day 7 but, whereas the BPL DI virus-treated mice died at day 8, mice given active DI virus cleared infectious virus completely by day 11. We found no evidence of persistent infection even when lung extracts (from mice killed at days 25 and 50) were inoculated directly into embryonated eggs and serially passaged undiluted (data not shown).
Distribution of virat antigen in the lung
Immunoperoxidase staining with hyperimmune antiserum showed that the virus was multiplying predominantly in cells of the bronchial epithelium. Viral antigen was abundantly present both in nucleus and cytoplasm. There were no differences at 3 or 5 days post-infection in the extent of infection or number of virus-infected cells in the lung tissue between infected mice treated with DI or BPL DI virus nor were there any differences in the distribution of virus antigen within infected cells (data not shown).
Are interferons stimulated by DI WSN?
Assay of the combined activity of alpha, beta and gamma interferons present in lung extracts showed that there were no significant differences between infected mice treated with active or inactive DI virus (Fig. 4) . Since it was possible that different ratios of interferons alpha/beta to gamma were responsible for the survival of mice, preparations were re-assayed after destruction of gamma interferon at low pH. The resulting titres were not significantly decreased, indicating that at best gamma interferon is a minor component in this infection.
Assay of serum and lung HI antibody responses
HI antibody was detected in serum on day 3. There was little difference in titre between the two experimental groups up to the time of death and values were around 1/200 by day 5 (data not shown). No HI antibody was detected in extracts of lungs from either group of mice unless the extracts were first acidified to dissociate antigen-antibody complexes. Titres from infected mice treated with BPL DI WSN were only marginally greater than those from mock-infected controls or controls inoculated with BPL DI or active DI virus alone (Fig. 5) . However, infected mice coinoculated with DI WSN were positive for HI antibody at 3 days post-infection and titres reached a peak after 5 days at a level 10-fold higher than in infected mice treated with BPL DI virus. This antibody had presumably been complexed to HA antigen. We then questioned whether the antibody response was being enhanced by active DI virus or if it was being depressed by BPL DI virus. As mice infected with WSN in the absence of added DI virus showed no detectable antibody synthesis (data not shown), we concluded that DI virus was, in some unknown way, enhancing antibody synthesis. One possible explanation was that active DI virus stimulated the synthesis of immunogenic non-infectious viral HA antigen.
Is there increased viral HA antigen in the lungs of DI WSN-treated mice?
The total HA antigen in non-acidified lung extracts was measured by ELISA using a monospecific polyclonal anti-HA capture system (Fig. 6) . The kinetics of antigen synthesis closely followed those of infectious virus (Fig. 3) and there was no difference between infected groups inoculated with active or BPL-treated DI virus. Confirmation that levels of virus synthesis were similar was obtained by assay of viral neuraminidase activity in lung extracts using fetuin as substrate (data not shown).
! I
Immunomodulation by DI influenza virus 
Neutralization by lung and serum antibody
HI antibodies collected from the lungs and serum at 5 days post-infection were also assayed for neutralizing activity by plaque assay on monolayers of chick embryo cells. A pool of convalescent serum taken from mice surviving at 3 weeks post-infection was used as a standard. We found that antibodies present in the lungs of mice treated with active DI virus or BPL DI virus (data not shown) had no detectable neutralizing activity, and neutralization:HI ratios were over 10-fold lower than the standard serum (Table 1) . Serum antibody, taken from the same mice, was of intermediate neutralization titre. Thus, the major proportion of HI lung antibody is either poorly neutralizing or devoid of neutralizing activity and this explains how infectious virus and antibody can coexist in the lungs at the same time. We do not yet know if lung antibody consists of a majority of HI-non-neutralizing antibody which recognizes antigenic sites different from those which result in neutralization (Wiley et al., 1981 ; Caton et al., 1982) or if our data are indicative of an overall low avidity neutralizing antibody.
Assay for DI WSN in mouse lung Assay for DI virus-specific interference using a procedure which measures the inhibition of the cytolytic activity of challenge virus in MDCK cells failed to detect DI virus in any lung extract, even in mice which were clearly protected by the DI virus.
DISCUSSION
We have shown that DI WSN protects mice from lethal infection with WSN virus without decreasing the amount of virus multiplication in the lungs or detectably altering the expression of virus antigen. To our knowledge this is the first exar~ple of DI virus interference which is not mediated by the inhibition of some aspect of virus multiplication. How then does DI WSN exert the observed very substantial protection ? We suggest that the answer lies in the fact that the pathology of influenza in the mouse is immune-mediated (Hurd & Heath, 1975; Suzuki et al., 1974; Sullivan et aL, 1976; Wyde eta/., 1977; Wyde & Cate, 1978) with a substantial contribution from delayed-type hypersensitivity T lymphocytes (Td cells) (Leung &Ada, 1980; Ada et al., 1981 ; Liew & Russell, 1983) . Thus, we conclude that DI WSN is directly or indirectly suppressing the immune pathology, but at the present time we have no information as to how this is brought about. However, the histopathological data show no gross qualitative or quantitative alterations in the lung lesions, just that they are less extensive in DI virus-treated mice. One clue for future investigation are data showing that the damaging Td cell response can be controlled by suppressor T cells (Ts cells) generated during infection (Liew & Russell, 1980) , whereas cytotoxic (Tc) cells clear virus and are protective in infected mice Lin & Askonas, 1980; Webster & Askonas, 1980) . Thus, DI WSN might act by stimulating Ts or Tc cells or by inhibiting Td ceils. The interlocking positive and negative controls at work in the immune system make detailed speculation of little value, but obviously helper activity and the possible effects of antiviral antibody are just two of many factors which have also to be borne in mind (see below).
In addition to a putative effect on T cells we found that DI WSN also stimulates the local HI antibody response by an order of magnitude. This response does not appear to be purely antigendriven as there was no difference in the amount of HA antigen in the lungs of either experimental group. DI WSN thus appears to modulate aspects of both T cell and B cell responses.
While not wishing to extrapolate too far from such preliminary immunological data it is possible to formulate a hypothesis which links the suppression of T cell damage with the increased amount of HI antibody in the lungs of mice treated with active DI virus. We suggest that HI antibody binds to and masks cell surface HA antigen, thus preventing it from being detected by effector T cells. Evidence presented above that antibody in the lung is complexed to HA and had a very low neutralizing capacity in relation to its HA binding (HI) activity is consistent with the hypothesis. The notion that T cell responses are B cell/antibody-modulated is not widespread (Gilbert & Hoffman, 1983) and such competition between the two major arms of the immune system is said not to occur (Doherty, 1985) . However, there are precedents: in herpes simplex virus infections of mice Td cells are modulated by a specific B lymphocyte response (Nash & GeU, 1980) ; in ectromelia virus infections the Tc response can be inhibited by antibody (Pang & Blanden, 1976) ; Tc cell lysis of poxvirus- (Koszinowski & Thomssen, 1975; Senik & Neauport-Santes, 1979) , VSV- (Hale et al., 1978) and reovirus- (Finberg et al., 1981 (Finberg et al., , 1982 infected target ceils in vitro are all inhibited by antiviral antibodies. And lastly in the influenza system itself, there is evidence that Tc responses can be modulated under some experimental circumstances by anti-HA antibody (Effros et al., 1979; Doherty et al., 1983) .
The reason why there is an increased amount of lung HI antibody in the DI virus-modulated infection also requires explanation as there appears to be no increased immunogenic stimulus. At present, we do not know whether DI virus is stimulating B cell helper activity, inhibiting B cell suppressors or enhancing antigen processing and presentation.
Whatever the details of the immunological involvement, it is clear that DI WSN does not protect mice by interfering with virus multiplication. Furthermore, since the DI virus interferes in vitro we conclude that DI WSN has one activity concerned with inhibition of multiplication (the conventional view of DI virus) and another activity which protects mice through modulating immune responses. This view is supported by other (unpublished) results showing that the mouse-protecting activity is less stable than interference measured in cell culture.
Using a different virus and a different mouse system, and Barrett & Dimmock (1984b) also arrived at the conclusion that DI viruses have immunomodulatory as well as virus interfering properties. Treatment of mice infected with SFV prevented disease and death but one preparation of DI virus (DI SFV p4) prevented the establishment of protective immunity to SFV. Thus, when these mice were re-inoculated at 3 weeks after the initial infection with SFV, they succumbed, with the fatal encephalitis taking its normal course. On the other hand mice protected with another DI virus (DI SFV p13) were solidly immune to challenge. The conclusion that naturally occurring defective virus variants can modulate immune responses gives a new dimension to the idea that DI viruses are elements concerned with the autoregulation of infection (Huang, 1982) .
The final problem is the apparent absence of DI WSN detectable by our very sensitive bioassay for interference, despite the obvious effects of DI virus in those mice. It is interesting that a similar failure to find DI virus was reported for SFV infection of mice . While there is at present no obvious explanation for these results, we intend to use molecular probes to search for DI sequences in mouse tissue as used successfully for VSV DI genomes (Cave et al., 1985) . We shall of course investigate cells of the immune system to see if they contain DI virus RNA.
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